Literature DB >> 23322428

[Vaccinations in patients with immunodeficiency or immunosuppressive therapy].

D Boršo1, M Löbermann, C Fritzsche, C Hemmer, A Führer, U Zettl, E C Reisinger.   

Abstract

Patients with immunodeficiency and patients under immunosuppressive therapy have an increased risk of infectious diseases. Vaccination strategies are needed to protect them from preventable diseases. The underlying disease and severity of the immune impairment may have influence on indications and contra-indications of vaccines. Inactivated vaccines can be administered safely according to the current recommendations of the Permanent Commission on Vaccinations of the Robert-Koch-Institut in Berlin, Germany (STIKO). Depending on the severity of the immune dysfunction, antibody response to vaccinations varies. Where possible, the antibody response following vaccinations should be tested. Previously, attenuated live vaccines were considered to be strictly contra-indicated in immunocompromised patients. Today, the administration of attenuated live vaccines is thought to be possible, depending on the degree and type of immunodeficiency or immunosuppression of the individual. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23322428     DOI: 10.1055/s-0032-1327401

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  [Secondary immunodeficiency in rheumatological diseases].

Authors:  D Ernst; R E Schmidt; T Witte
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

2.  [How well are patients with inflammatory rheumatic diseases protected against measles?]

Authors:  U Kiltz; A Celik; S Tsiami; X Baraliakos; I Andreica; D Kiefer; B Bühring; J Braun
Journal:  Z Rheumatol       Date:  2020-09-15       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.